分子印迹光子晶体凝胶传感器检测食品中的着色剂姜黄素

开发一种分子印迹光子晶体凝胶传感器,用于快速检测食品中的着色剂姜黄素。以聚苯乙烯微球阵列为模板,姜黄素为印迹分子,借助"三明治"结构,热引发聚合后除去模板和印迹分子,制备具有良好光学性质的传感器,通过红外光谱、扫描电镜对其进行表征,考察其响应性、平衡时间、选择性等,再利用该传感器检测实际样品中的姜黄素含量。结果表明:该传感器具有相互贯通的三维有序大孔结构;当姜黄素浓度增加到0. 12 mmol/L时,吸收峰位移变化最大为97 nm,并伴有明显的颜色变化。方法用于姜黄素分析,检出限为0. 57μmol/L;响应时间50 s。本方法用于小米和果冻中姜黄素的检测,回收率分别为94. 4%和87. 1%,为复杂样品中的姜黄素检测提供了一种可能的途径。     

基于吐温-姜黄素复合物的荧光探针检测脂肪酶活性

本实验以姜黄素作为信号探针,吐温作为脂肪酶的底物和包裹姜黄素的载体,建立了一种检测脂肪酶活性的荧光法.实验发现,采用0.3 mmol/L吐温40,25 μmol/L姜黄素,并且脂肪酶水解吐温40的时间为35 min时,姜黄素的荧光强度变化值与脂肪酶浓度在0.002 ～0.05 mg/mL和0.05～0.25 mg/mL范围内呈现线性关系,检出限为0.6 mg/L (S/N=3).此探针在高通量检测脂肪酶活性以及与脂肪酶相关疾病检测领域中有较好的应用前景.     

姜黄素对食管癌KYSE410细胞的生长抑制与氧化调节

通过四氮唑蓝盐化合物(MTS)和重要氧化还原酶及其代谢物的试剂盒检测等方法, 考察了姜黄素对食管癌KYSE410细胞生长以及对细胞氧化还原状态和代谢的影响. 结果表明, 姜黄素对KYSE410细胞具有较强的抑制作用, 其IC₅₀=17.9 μmol/L. 进一步研究发现, 姜黄素可引起细胞培养上层清液中超氧化物歧化酶(SOD)和丙二醛(MDA)水平发生变化. 当姜黄素浓度为40 μmol/L时, MDA水平比对照组提高了125.1%, 而SOD水平则降低了43.2%; 同时, 乳酸水平降低了44.4%, 乳酸脱氢酶的活性下降了58.2%, 丙酮酸激酶的活性升高了216.7%. 姜黄素可能通过干扰氧化还原途径, 致使发生脂质过氧化反应, 并抑制肿瘤细胞糖酵解作用, 进而抑制食管癌KYSE410细胞增殖.     

姜黄素的电化学性质及其测定

在0.1 mol/L磷酸盐缓冲液(pH 3.0)中,姜黄素于玻碳电极上存在可逆的单电子转移过程,据此,本文建立了以差示脉冲伏安扫描法检测姜黄素含量的新方法.在+0.8V(vs.SCE)电位下,含姜黄素的电解液(试样)于玻碳电极上经过富集,可得一灵敏的还原峰,峰电位Ep为+0.386V.峰电流Ip与姜黄素浓度(1.0×10-8~2.5×10-7mol/L范围内)成线性关系,最低检出限为4.0×10-9mol/L.本法操作简单、快速、灵敏、准确,可用于药物中姜黄素含量直接测定.     

姜黄中姜黄素的提取及电化学测定

姜黄中大约含有1%～3%的姜黄素,用95%乙醇从姜黄中浸取姜黄素,超声场介入下浸取的浸取速率最快.在0.2 mol/L磷酸盐缓冲溶液中（pH3.3）,姜黄素于玻碳电极上存在可逆的单电子转移过程,据此本实验首次建立了以线性扫描溶出伏安法检测姜黄素含量的新方法.在-0.2 V（vs SCE：饱和甘汞参比电极）电位下,含姜黄素的电解液于玻碳电极上经过富集,可得到一灵敏的氧化峰,峰电位Epa为＋0.464 V.在最佳条件下,氧化峰峰电流Ip与姜黄素浓度在8.0×10^-9～4.0×10^-7mol/L范围内呈线性关系,最低检出限为2.0×10^-9mol/L.本法操作简单、快速、灵敏、准确,可用于药物中姜黄素含量的直接测定.     

液相色谱-串联质谱联用技术检测人尿中去氨加压素及其在人尿中的消除研究

建立了液相色谱-串联质谱(LC-MS/MS)检测人尿中去氨加压素的方法。样品经Waters C_(18)固相萃取净化,Phenomenex Onyx Monolothic C_(18)色谱柱分离,以10 mmol/L甲酸铵水溶液(用甲酸调至p H 3.5)-乙腈作为流动相进行梯度洗脱,流速为0.4 m L/min,串联质谱正离子模式电离(ESI~+),多反应监测模式(MRM)检测。收集8名志愿者在服用单次单剂量去氨加压素后留取3 d内全部尿液样本,使用建立的方法进行检测并绘制代谢曲线。结果表明:尿中去氨加压素的检出限为0.2μg/L;线性范围为0.5~20μg/L,相关系数(r~2)大于0.997;在低、中、高3个加标浓度下,回收率均高于59%,日内及日间精密度均小于10%,基质效应在20%以内。8名志愿者的阳性尿中去氨加压素浓度峰值在服药后70~150 min之间,最高浓度为0.2~2.4μg/L,检测窗口期最长可至服药后13 h左右。该法对于尿中去氨加压素具有特异性,能显著降低实验时间和成本,完全满足世界反兴奋剂组织对该药物的检测要求。该实验考察了服药后阳性尿中去氨加压素的浓度变化,研究了去氨加压素在人体内的消除情况。     

荧光碳点对生物体液中姜黄素的检测及细胞成像

本文以廉价易得的橘皮和柠檬酸为原料，通过一步水热法合成荧光碳点(CDs)。对CDs的形貌、结构、元素组成和光学性能等进行了表征，考察了离子强度、光稳定性和储存时间对CDs的影响。所合成CDs为粒径约为4 nm的类球形结构，具有较好的稳定性。通过对CDs与姜黄素(CM)检测体系的选择性实验，发现常见的离子及氨基酸对CM的检测几乎无影响。基于CM对CDs选择性荧光猝灭的现象，构建了检测姜黄素的荧光探针。在最佳实验条件下，该探针对CM检测的线性范围为5～40μmol/L,检出限为9.7 nmol/L。探讨了CDs和CM作用机理，发现其主要是静态猝灭。该CDs应用于健康人体体液(血液、尿液)中微量CM的测定，其加标回收率为104.0%～115.0%。橘皮合成碳点可用于A549细胞进行成像，并表现出低细胞毒性。实验结果表明，该CDs在CM的分析检测以及细胞成像中具有较好的应用价值。     

反向流动注射化学发光法测定姜黄素

铁氰化钾氧化鲁米诺在碱性介质中产生化学发光,姜黄素对该体系化学发光具有强烈的抑制作用。因此,利用该化学发光的抑制体系,结合反向流动注射技术,建立了测定大黄类药物姜黄素含量的新方法。在优化的条件下,化学发光抑制信号强度ΔI与姜黄素的浓度分别在1×10-7~1×10-6和1×10-6~1×10-5mol/L范围内呈良好的线性关系,检出限为1×10-9mol/L。对2.0×10-6mol/L的姜黄素进行平行测定10次,得相对标准偏差(RSD)为1.8%。方法应用于中药姜黄中姜黄素(总姜黄素计)的含量测定。     

液相色谱-串联质谱法同时测定猪尿中23种违禁药物

建立了液相色谱-电喷雾串联质谱同时测定猪尿液中β-受体激动剂类、激素类、硝基咪唑类和镇静剂类等23种违禁药物多残留分析方法。猪尿试样真空冷冻干燥后,采用Anpel MCX固相萃取小柱净化,经CNW Athena C18色谱柱(150 mm×2.1 mm,5μm)分离,多反应监测模式下进行定性与定量分析。采用基质匹配标准溶液校正,23个药物响应值与其相应质量浓度在0.5～100μg/L范围内呈良好的线性关系,相关系数(r)大于0.99;以3倍和10倍信噪比计算得到的方法检出限和定量限分别为0.5～4.0μg/L和1.0～10μg/L;在4个添加水平定量限、10、20及50μg/L,猪尿中23种药物的平均回收率为50.2%～97.7%;日内相对标准偏差(RSD)小于10%,日间RSD小于18%。应用此方法检测200批次不同来源猪尿,其中2批次检测出克伦特罗,浓度为4.45和2.16μg/L。     

高效液相色谱法检测食品中姜黄素类化合物

建立了食品中姜黄素类化合物的液相色谱分析方法。采用甲醇提取试样中姜黄素及其同系物去甲氧基姜黄素和双去甲氧基姜黄素,以YMCTMCarotenoid色谱柱(250 mm×4.6 mm,5μm)分离,甲醇水溶液(A)-甲基叔丁基醚(B)梯度洗脱。对所分析化合物的稳定性、前处理条件及色谱条件进行考察。3种分析物在0.5~100μg/mL范围内线性关系良好,相关系数为0.997 7~0.999 8。在10~100 mg/kg加标浓度范围内,平均回收率为72.2%~102%,相对标准偏差为3.4%~13.8%。对姜黄素、去甲氧基姜黄素和双去甲氧基姜黄素的检出限分别为6、5、5 mg/kg。方法稳定、可靠,已应用于实际样品的检测。     

高效液相色谱-串联质谱法同时测定人尿液中7种邻苯二甲酸酯代谢物

建立了同时检测人尿液中7种邻苯二甲酸酯代谢物的高效液相色谱-串联三重四极杆质谱法。尿液经酶水解后,采用萃取柱净化,以2%(v/v)甲酸甲醇溶液为洗脱剂,经苯基柱分离,以0.1%(v/v)乙酸水溶液和0.1%(v/v)乙酸乙腈溶液为流动相进行梯度洗脱,采用电喷雾离子源负离子模式和多反应监测模式采集信号,用同位素内标法进行定量分析。尿液中7种邻苯二甲酸酯代谢物在0.2~200.0 μg/L范围内定量离子的相对峰面积比值与质量浓度均呈良好线性关系(r≥0.99976);检出限(LOD)为13.43~80.21 ng/L,定量限为44.77~267.37 ng/L; 3个水平的加标回收率为88.8%~108.9%,日内和日间精密度均不大于17.05%。该方法可同时准确、灵敏、简便地测定人尿液中7种邻苯二甲酸酯代谢物的暴露水平。     

超高效液相色谱-三重四极杆质谱法测定人尿中9种邻苯二甲酸酯代谢物

建立了人尿中9种邻苯二甲酸酯（PAE）代谢物的超高效液相色谱-三重四极杆质谱（UPLC-MS/MS）测定方法。2 mL尿液样本酶解2 h后,经强阴离子固相萃取净化处理;选用Waters ACQUITY UPLC BEH Phenyl色谱柱（100 mm×2.1 mm,1.7 μ m）,以0.1%（体积分数）乙酸乙腈和0.1%（体积分数）乙酸水溶液为流动相进行梯度洗脱;在负离子电喷雾多反应监测模式（MRM）下测定9种PAE代谢物含量。8种PAE代谢物在0.39~200 μ g/L范围内、1种PAE代谢物在1.17~600 μ g/L范围内线性关系良好,相关系数均大于0.995。方法检出限为0.06~0.85 μ g/L,定量限为0.20~2.80 μ g/L。3个加标水平的加标回收率为84.1%~122%,精密度为4.5%~14.3%;日内精密度不高于9.3%,日间精密度不高于10.1%;基质效应和稳定性符合分析要求。应用该方法测定50份人尿液样本,邻苯二甲酸单环已酯（MCHP）和邻苯二甲酸单苄酯（MBZP）的检出率分别为0和44.0%,其余7种PAE代谢物的检出率为100%。该方法操作简单、定量准确、稳定性好,适用于人尿中9种PAE代谢物的定量分析。     

An HPLC‐UV method for the simultaneous quantification of curcumin and its metabolites in plasma and lung tissue: Potential for preclinical applications

Curcumin, derived from turmeric, has been extensively investigated for its broad spectrum of biological activities. Previously reported HPLC‐UV methods have focussed on analysis of the parent compound. Here, a sensitive HPLC‐UV method was developed and partially validated, then used for the simultaneous determination of curcumin and its glucuronide and sulfate metabolites in plasma and lung tissue from mice. The assay was applied to an in vivo pharmacokinetic study comparing formulated curcumin (Meriva™) with standard curcumin. Plasma levels of glucuronide and sulfate metabolites were 5‐ and 2‐fold higher after Meriva™ administration compared with standard curcumin. In lung tissue, free curcumin was 4‐fold higher following Meriva™ administration vs standard curcumin. This assay represents a rapid, cheap method for simultaneous detection of curcumin and its major metabolites that has applicability in pre‐clinical settings.     

固相萃取/超高效液相色谱-串联质谱法测定尿液中6种双酚类及烷基酚类物质

建立了超高效液相色谱-串联质谱测定人体尿液中双酚A(BPA)、双酚F(BPF)、四氯双酚A(TCBPA)、四溴双酚A(TBBPA)、壬基酚(NP)、4-正辛基苯酚(4-n-OP)的检测方法。尿液样品通过酶解和固相萃取法进行前处理,采用Acquity UPLC HSS T3色谱柱(2.1 mm×100 mm,1.8μm)分离,负离子电喷雾多反应监测模式检测,同位素内标法定量。6种待测物在0.5~50μg/L范围内线性关系良好,相关系数均大于0.995,检出限为0.05~0.60μg/L,定量下限为0.17~2.00μg/L,2、10、50μg/L加标水平下的回收率为81.4%~112%,相对标准偏差(RSD,n=6)为6.8%~30%。应用此方法测定160份人体尿液样品,双酚A的检出率为93.8%,检出范围为0.24~29.54μg/L,其余目标物未检出。该方法操作简便、重现性好、定量准确,适用于人体尿液中双酚类及烷基酚类物质的测定。     

Rapid measurements of curcumin from complex samples coupled with magnetic biocompatibility molecularly imprinted polymer using electrochemical detection

Curcumin widely exists in food, and rapid selective and accurate detection of curcumin have great significance in chemical industry. In this experiment, a new magnetic biocompatibility molecularly imprinted polymer was prepared with nontoxic and biocompatible Zein to adsorb curcumin selectively. The polymer has high biocompatibility, good adsorption capacity, and specific adsorption for curcumin. Combined with portable electrochemical workstations, the polymer can be used to detect curcumin rapidly and cost‐effectively. Using curcumin as a template and Zein as the crosslinking agent, the polymers were synthesized on the surface of Fe₃O₄ particles for solid phase extraction. The experimental results showed that the polymer reached large adsorption capacity (32.12 mg/g) with fast kinetics (20 min). The adsorption characteristic of the polymer followed the Langmuir isotherm and pseudo‐second‐order kinetic models. Hexacyanoferrate was used as electrochemical probe to generate signals, and the linear range was 5–200 µg/mL for measuring curcumin. The experimental analysis showed that the polymer was an ideal material for selective accumulation of curcumin from complex samples. This approach has been successfully applied to the determination of curcumin in food samples with electrochemical detection, indicating that this is a feasible and practical technique.     

固相萃取-高效阴离子交换色谱-积分脉冲安培法检测人体尿液中的异黄蝶呤

建立了固相萃取-高效阴离子交换色谱-积分脉冲安培法(SPE-HPAEC-IPAD)测定人体尿液中异黄蝶呤的分析方法。尿液经ENVI-18与732型阳离子交换柱串联萃取后,除去了大量干扰物质。采用IonPac AS21分析柱(250 mm×2 mm),以0.025 mol/L NaOH溶液为淋洗液,流速为0.40 mL/min,在优化的安培检测波形条件下,异黄蝶呤的质量浓度在0.005～0.200 mg/L范围内与峰面积呈良好的线性关系,相关系数为0.998 4,检出限为0.003 mg/L。健康人及癌症病人尿液在2 mg/L和5 mg/L两个添加水平的平均回收率在95.4%～96.8%之间,相对标准偏差小于5%。此方法环保、快速、准确,可用于健康人与癌症病人尿液中异黄蝶呤的测定。     

Comparison between external and internal standard calibration in the validation of an analytical method for 1-hydroxypyrene in human urine by high-performance liquid chromatography/tandem mass spectrometry

1-Hydroxypyrene is a metabolite of pyrene, a member of the class of polycyclic aromatic hydrocarbons (PAHs) whose toxic properties in some cases include carcinogenicity. The determination of 1-hydroxypyrene in human urine is used as a biological indicator for exposure to PAHs, which is related to the combustion of organic materials, like smoking, living in urban environments, and eating grilled or smoked food. The determination of 1-hydroxypyrene by high-performance liquid chromatography (HPLC) with fluorescence detection has very good sensitivity but it is not highly specific: this can reduce accuracy in the quantitative determination of low levels of analyte in a complex matrix like urine. An HPLC method that uses triple quadrupole mass detection has been validated with the objective both to improve the signal-to-noise (S/N) ratio and to achieve the maximum specificity for the analyte in those urine samples that are richer in possible inteferents. The calibration range for 1-hydroxypyrene is from 0.005-0.1 microg/L in the urine of non-smoking healthy volunteers. After solid-phase extraction, samples were analyzed by HPLC/tandem mass spectrometry (MS/MS) in the multiple reaction monitoring (MRM) mode. In order to obtain reliable results quantitative analysis must be performed by means of the internal standard method (we used deuterium-labelled 1-hydroxypyrene): the method accuracy is not less than 85%. The S/N ratio at a concentration of 0.1 microg/L is about 10, and therefore this can be considered the lowest limit of quantitation. The method performance does not change if urine samples are measured using a calibration curve prepared in methanol, thus reducing the time of analysis and costs.     

A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health

Curcumin is the most important active component in turmeric extracts. Curcumin, a natural monomer from plants has received a considerable attention as a dietary supplement, exhibiting evident activity in a wide range of human pathological conditions. In general, curcumin is beneficial to human health, demonstrating pharmacological activities of anti-inflammation and antioxidation, as well as antitumor and immune regulation activities. Curcumin also presents therapeutic potential in neurodegenerative, cardiovascular and cerebrovascular diseases. In this review article, we summarize the advancements made in recent years with respect to curcumin as a biologically active agent in malignant tumors, Alzheimer’s disease (AD), hematological diseases and viral infectious diseases. We also focus on problems associated with curcumin from basic research to clinical translation, such as its low solubility, leading to poor bioavailability, as well as the controversy surrounding the association between curcumin purity and effect. Through a review and summary of the clinical research on curcumin and case reports of adverse effects, we found that the clinical transformation of curcumin is not successful, and excessive intake of curcumin may have adverse effects on the kidneys, heart, liver, blood and immune system, which leads us to warn that curcumin has a long way to go from basic research to application transformation.     

Curcumin Inhibits Lysophosphatidic Acid Mediated MCP-1 Expression via Blocking ROCK Signalling

Curcumin is a natural compound that has been widely used as a food additive and medicine in Asian countries. Over several decades, diverse biological effects of curcumin have been elucidated, such as anti-inflammatory and anti-oxidative activities. Monocyte chemoattractant protein-1 (MCP-1) is a key inflammatory marker during the development of atherosclerosis, and curcumin blocks MCP-1 expression stimulated by various ligands. Hence, we studied the action of curcumin on lysophosphatidic acid (LPA) mediated MCP-1 expression and explored the specific underlying mechanisms. In human vascular smooth muscle cells, LPA induces Rho-associated protein kinase (ROCK) dependent transforming growth factor receptor (TGFBR1) transactivation, leading to glycosaminoglycan chain elongation. We found that LPA also signals via the TGFBR1 transactivation pathway to regulate MCP-1 expression. Curcumin blocks LPA mediated TGFBR1 transactivation and subsequent MCP-1 expression by blocking the ROCK signalling. In the vasculature, ROCK signalling regulates smooth muscle cell contraction, inflammatory cell recruitment, endothelial dysfunction and vascular remodelling. Therefore, curcumin as a ROCK signalling inhibitor has the potential to prevent atherogenesis via multiple ways.